125 related articles for article (PubMed ID: 21127468)
1. Urinary β-2-microglobulin as an alternative marker for fetal inflammatory response and development of bronchopulmonary dysplasia in premature infants.
Shima Y; Nishimaki S; Nakajima M; Kumasaka S; Migita M
J Perinatol; 2011 May; 31(5):330-4. PubMed ID: 21127468
[TBL] [Abstract][Full Text] [Related]
2. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia.
Paananen R; Husa AK; Vuolteenaho R; Herva R; Kaukola T; Hallman M
J Pediatr; 2009 Jan; 154(1):39-43.e3. PubMed ID: 18760808
[TBL] [Abstract][Full Text] [Related]
3. Comparison of markers for fetal inflammatory response syndrome: fetal blood interleukin-6 and neonatal urinary beta(2)-microglobulin.
Nishimaki S; Sato M; An H; Shima Y; Akaike T; Yokoyama U; Yokota S
J Obstet Gynaecol Res; 2009 Jun; 35(3):472-6. PubMed ID: 19527385
[TBL] [Abstract][Full Text] [Related]
4. Urinary beta 2-microglobulin in premature infants with chorioamnionitis and chronic lung disease.
Nishimaki S; Shima Y; Sato M; An H; Hashimoto M; Nishiyama Y; Iwasaki S; Tateishi I; Seki K; Yokota S
J Pediatr; 2003 Jul; 143(1):120-2. PubMed ID: 12915837
[TBL] [Abstract][Full Text] [Related]
5. Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia.
Kewitz G; Wudel S; Hopp H; Hopfenmüller W; Vogel M; Roots I
J Perinat Med; 2008; 36(4):359-64. PubMed ID: 18598128
[TBL] [Abstract][Full Text] [Related]
6. Chorioamnionitis, lung function and bronchopulmonary dysplasia in prematurely born infants.
Prendergast M; May C; Broughton S; Pollina E; Milner AD; Rafferty GF; Greenough A
Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F270-4. PubMed ID: 21097839
[TBL] [Abstract][Full Text] [Related]
7. Urinary β2-microglobulin and bronchopulmonary dysplasia: Trends in preterm infants.
Shima Y; Kumasaka S; Nishimaki S
Pediatr Int; 2017 Nov; 59(11):1169-1173. PubMed ID: 28833913
[TBL] [Abstract][Full Text] [Related]
8. Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia.
Kent A; Dahlstrom JE
J Paediatr Child Health; 2004 Jul; 40(7):356-9. PubMed ID: 15228562
[TBL] [Abstract][Full Text] [Related]
9. Amniotic fluid transforming growth factor-beta1 and the risk for the development of neonatal bronchopulmonary dysplasia.
Ichiba H; Saito M; Yamano T
Neonatology; 2009; 96(3):156-61. PubMed ID: 19332995
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants.
Viscardi RM; Muhumuza CK; Rodriguez A; Fairchild KD; Sun CC; Gross GW; Campbell AB; Wilson PD; Hester L; Hasday JD
Pediatr Res; 2004 Jun; 55(6):1009-17. PubMed ID: 15155869
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory cytokines in gastric fluid at birth and the development of bronchopulmonary dysplasia.
Stichel H; Bäckström E; Hafström O; Nilsson S; Lappalainen U; Bry K
Acta Paediatr; 2011 Sep; 100(9):1206-12. PubMed ID: 21438921
[TBL] [Abstract][Full Text] [Related]
12. MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD.
Fukunaga S; Ichiyama T; Maeba S; Okuda M; Nakata M; Sugino N; Furukawa S
Pediatr Pulmonol; 2009 Mar; 44(3):267-72. PubMed ID: 19205055
[TBL] [Abstract][Full Text] [Related]
13. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.
Sheikh S; Null D; Gentile D; Bimle C; Skoner D; McCoy K; Guthrie R
Chest; 2001 Jun; 119(6):1749-54. PubMed ID: 11399701
[TBL] [Abstract][Full Text] [Related]
14. Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants.
Choi CW; Kim BI; Kim HS; Park JD; Choi JH; Son DW
Acta Paediatr; 2006 Jan; 95(1):38-43. PubMed ID: 16373294
[TBL] [Abstract][Full Text] [Related]
15. Oral mucosal microvascular abnormalities: an early marker of bronchopulmonary dysplasia.
de Felice C; Latini G; Parrini S; Bianciardi G; Toti P; Kopotic RJ; Null DM
Pediatr Res; 2004 Dec; 56(6):927-31. PubMed ID: 15470198
[TBL] [Abstract][Full Text] [Related]
16. Chorioamnionitis is essential in the evolution of bronchopulmonary dysplasia--the case in favour.
Thomas W; Speer CP
Paediatr Respir Rev; 2014 Mar; 15(1):49-52. PubMed ID: 24128984
[TBL] [Abstract][Full Text] [Related]
17. Histological chorioamnionitis and neonatal leukemoid reaction in low-birth-weight infants.
Zanardo V; Vedovato S; Trevisanuto DD; Suppiej A; Cosmi E; Fais GF; Chiarelli S
Hum Pathol; 2006 Jan; 37(1):87-91. PubMed ID: 16360420
[TBL] [Abstract][Full Text] [Related]
18. Blood cytokines and BPD.
Jobe AH
J Pediatr; 2009 Jan; 154(1):A2. PubMed ID: 19187720
[No Abstract] [Full Text] [Related]
19. Urinary F2-isoprostanes are poor prognostic indicators for the development of bronchopulmonary dysplasia.
Reuter SD; O'Donovan DJ; Hegemier SE; Smith EO; Heird WC; Fernandes CJ
J Perinatol; 2007 May; 27(5):303-6. PubMed ID: 17363910
[TBL] [Abstract][Full Text] [Related]
20. Potential biochemical growth markers in premature infants.
Bhandari V; Fall P; Raisz L; Rowe J
Am J Perinatol; 1999; 16(7):339-49. PubMed ID: 10614701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
